Skip to main content
SpringerLink
Log in
Book cover

Management of Pediatric Obesity and Diabetes pp 367–405Cite as

Secondary Causes of Obesity in Childhood

  • Chapter
  • First Online:

  • 1856 Accesses

Part of the book series: Nutrition and Health ((NH))

Key Points

Secondary causes of obesity are frequent and must be diagnosed to assure optimal clinical care.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Speiser PW, Rudolf MC, Anhalt H et al. (2005) Consensus statement: childhood obesity. J Clin Endocrinol Metab 90:1871–1887

    Article  PubMed  CAS  Google Scholar 

  2. Kiess W, Galler A, Reich A et al. (2001) Clinical aspects of obesity in childhood and adolescence. Obes Rev 2:29–36

    Article  PubMed  CAS  Google Scholar 

  3. Barlow SE (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(Suppl 4):S164–S192

    Article  PubMed  Google Scholar 

  4. Stefan M, Nicholls RD (2004) What have rare genetic syndromes taught us about the pathophysiology of the common forms of obesity? Curr Diab Rep 4:143–150

    Article  PubMed  Google Scholar 

  5. Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D (2007) Assessment of child and adolescent overweight and obesity. Pediatrics 120(Suppl 4):S193–S228

    Article  PubMed  Google Scholar 

  6. Prader A, Labhart A, Willi H (1956) Ein syndrom von adipositas, kelinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter. Schweiz Med Wochenschr 86:1260–1261

    Google Scholar 

  7. Chen C, Visootsak J, Dills S, Graham JM Jr (2007) Prader–Willi syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) 46:580–591

    Article  CAS  Google Scholar 

  8. Cassidy SB, Driscoll DJ (2009) Prader–Willi syndrome. Eur J Hum Genet 17:3–13

    Article  PubMed  CAS  Google Scholar 

  9. Bittel DC, Butler MG (2009) Prader–Willi syndrome. In: Squire LR (ed) Encyclopedia of neuroscience. Academic Press, London, pp 873–883

    Chapter  Google Scholar 

  10. Burman P, Ritzen EM, Lindgren AC (2001) Endocrine dysfunction in Prader–Willi syndrome: a review with special reference to GH. Endocr Rev 22:787–799

    Article  PubMed  CAS  Google Scholar 

  11. Kousta E, Hadjiathanasiou CG, Tolis G, Papathanasiou A (2009) Pleiotropic genetic syndromes with developmental abnormalities associated with obesity. J Pediatr Endocrinol Metab 22:581–592

    Article  PubMed  CAS  Google Scholar 

  12. De Peppo F, Di Giorgio G, Germani M et al. (2008) BioEnterics intragastric balloon for treatment of morbid obesity in Prader–Willi syndrome: specific risks and benefits. Obes Surg 18:1443–1449

    Article  PubMed  Google Scholar 

  13. Holm VA, Cassidy SB, Butler MG et al. (1993) Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398–402

    PubMed  CAS  Google Scholar 

  14. Haqq AM, Stadler DD, Rosenfeld RG et al. (2003) Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader–Willi syndrome. J Clin Endocrinol Metab 88:3573–3576

    Article  PubMed  CAS  Google Scholar 

  15. De Waele K, Ishkanian SL, Bogarin R et al. (2008) Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader–Willi syndrome. Eur J Endocrinol 159:381–388

    Article  PubMed  CAS  Google Scholar 

  16. Shapira NA, Lessig MC, Lewis MH, Goodman WK, Driscoll DJ (2004) Effects of topiramate in adults with Prader–Willi syndrome. Am J Ment Retard 109:301–309

    Article  PubMed  Google Scholar 

  17. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H (2001) Population prevalence and estimated birth incidence and mortality rate for people with Prader–Willi syndrome in one UK health region. J Med Genet 38:792–798

    Article  PubMed  CAS  Google Scholar 

  18. Laurence JZ, Moon RC (1866) Four cases of retinitis pigmentosa occurring in the same family accompanied by general imperfections of development. Ophthalmol Rev 2:32–41

    Google Scholar 

  19. Klysik M (2008) Ciliary syndromes and treatment. Pathol Res Pract 204:77–88

    Article  PubMed  CAS  Google Scholar 

  20. Kokkoris P, Pi-Sunyer FX (2003) Obesity and endocrine disease. Endocrinol Metab Clin North Am 32:895–914

    Article  PubMed  CAS  Google Scholar 

  21. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA (1999) New criteria for improved diagnosis of Bardet–Biedl syndrome: results of a population survey. J Med Genet 36:437–446

    PubMed  CAS  Google Scholar 

  22. Waters AM, Beales PL (2010) Bardet–Biedl syndrome. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&partid=1363. Accessed 24 March 2010

  23. National Library of Medicine, Genetics Home Reference (2010) Alstrom syndrome. Available at: http://ghr.nlm.nih.gov/condition=alstromsyndrome. Accessed 24 March 2010

  24. Marshall JD, Beck S, Maffei P, Naggert JK (2007) Alstrom syndrome. Eur J Hum Genet 15:1193–1202

    Article  PubMed  CAS  Google Scholar 

  25. Li G, Vega R, Nelms K et al. (2007) A role for Alstrom syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 3:e8

    Article  PubMed  CAS  Google Scholar 

  26. Minton JA, Owen KR, Ricketts CJ et al. (2006) Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 91:3110–3116

    Article  PubMed  CAS  Google Scholar 

  27. Marshall JD, Bronson RT, Collin GB et al. (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683

    Article  PubMed  Google Scholar 

  28. Cohen MM Jr, Hall BD, Smith DW, Graham CB, Lampert KJ (1973) A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J Pediatr 83:280–284

    Article  PubMed  Google Scholar 

  29. NIH Office of Rare Diseases Research, Genetic and Rare Diseases Information Center (2010) Cohen syndrome. Available at: http://rarediseases.info.nih.gov/GARD/Condition/6126/Cohen_syndrome.aspx. Accessed 24 March 2010

  30. Kivitie-Kallio S, Eronen M, Lipsanen-Nyman M, Marttinen E, Norio R (1999) Cohen syndrome: evaluation of its cardiac, endocrine and radiological features. Clin Genet 56:41–50

    Article  PubMed  CAS  Google Scholar 

  31. Kolehmainen J, Black GC, Saarinen A et al. (2003) Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 72:1359–1369

    Article  PubMed  CAS  Google Scholar 

  32. Ballesta CG, Lajarin LP, Lillo OC (2010) Cohen syndrome. Available at: http://www.orpha.net/data/patho/GB/uk-cohen.pdf. Accessed 24 March 2010

  33. Falk MJ, Wang H, Traboulsi EI (2010) Cohen syndrome. In: GeneReviews at GeneTests: medical genetics information resource (database online). Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=cohen. Accessed 24 March 2010

  34. Taban M, Memoracion-Peralta DS, Wang H, Al-Gazali LI, Traboulsi EI (2007) Cohen syndrome: report of nine cases and review of the literature, with emphasis on ophthalmic features. J AAPOS 11:431–437

    Article  PubMed  Google Scholar 

  35. Ayme S, Olry A. Prevalence of rare diseases: bibliographic data listed in alphabetical order of diseases. Orphanet Report Series, Rare Diseases Collection. November 2009, Number 1. Available at: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed 24 March 2010

  36. Jenkins D, Seelow D, Jehee FS et al. (2007) RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 80:1162–1170

    Article  PubMed  CAS  Google Scholar 

  37. Goldstone AP, Beales PL (2008) Genetic obesity syndromes. Front Horm Res 36:37–60

    Article  PubMed  CAS  Google Scholar 

  38. Perlyn CA, Marsh JL (2008) Craniofacial dysmorphology of Carpenter syndrome: lessons from three affected siblings. Plast Reconstr Surg 121:971–981

    Article  PubMed  CAS  Google Scholar 

  39. Ramos JM, Davis GJ, Hunsaker JC III, Balko MG (2009) Sudden death in a child with Carpenter Syndrome. Case report and literature review. Forensic Sci Med Pathol 5:313–317

    Article  PubMed  Google Scholar 

  40. Suh JM, Gao X, McKay J, McKay R, Salo Z, Graff JM (2006) Hedgehog signaling plays a conserved role in inhibiting fat formation. Cell Metab 3:25–34

    Article  PubMed  CAS  Google Scholar 

  41. Hidestrand P, Vasconez H, Cottrill C (2009) Carpenter syndrome. J Craniofac Surg 20:254–256

    Article  PubMed  Google Scholar 

  42. Robinson LK, James HE, Mubarak SJ, Allen EJ, Jones KL (1985) Carpenter syndrome: natural history and clinical spectrum. Am J Med Genet 20:461–469

    Article  PubMed  CAS  Google Scholar 

  43. Bojesen A, Gravholt CH (2007) Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 4:192–204

    Article  PubMed  Google Scholar 

  44. Bojesen A, Juul S, Gravholt CH (2003) Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 88:622–626

    Article  PubMed  CAS  Google Scholar 

  45. Bojesen A, Kristensen K, Birkebaek NH et al. (2006) The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29:1591–1598

    Article  PubMed  Google Scholar 

  46. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E (2004) Klinefelter’s syndrome. Lancet 364:273–283

    Article  PubMed  CAS  Google Scholar 

  47. Laaksonen DE, Niskanen L, Punnonen K et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036–1041

    Article  PubMed  CAS  Google Scholar 

  48. Marin P, Holmang S, Jonsson L et al. (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991–997

    PubMed  CAS  Google Scholar 

  49. Bojesen A, Host C, Gravholt CH (2010) Klinefelter’s syndrome, type 2 diabetes and the metabolic syndrome – the impact of body composition. Mol Hum Reprod 16:396–401

    Article  PubMed  Google Scholar 

  50. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA (2005) Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab 90:6516–6522

    Article  PubMed  CAS  Google Scholar 

  51. Laaksonen DE, Niskanen L, Punnonen K et al. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 149:601–608

    Article  PubMed  CAS  Google Scholar 

  52. Bondy CA (2009) Turner syndrome 2008. Horm Res 71(Suppl 1):52–56

    Article  PubMed  CAS  Google Scholar 

  53. Morgan T (2007) Turner syndrome: diagnosis and management. Am Fam Physician 76:405–410

    PubMed  Google Scholar 

  54. Gravholt CH, Hjerrild BE, Mosekilde L et al. (2006) Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 155:583–592

    Article  PubMed  CAS  Google Scholar 

  55. Bakalov VK, Cooley MM, Quon MJ et al. (2004) Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516–3520

    Article  PubMed  CAS  Google Scholar 

  56. Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS (2005) Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab 90:2948–2953

    Article  PubMed  CAS  Google Scholar 

  57. Rubin KR (2008) Turner syndrome: transition from pediatrics to adulthood. Endocr Pract 14:775–781

    PubMed  Google Scholar 

  58. Montague CT, Farooqi IS, Whitehead JP et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908

    Article  PubMed  CAS  Google Scholar 

  59. Clement K, Vaisse C, Lahlou N et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398–401

    Article  PubMed  CAS  Google Scholar 

  60. Farooqi IS (2008) Monogenic human obesity. Front Horm Res 36:1–11

    Article  PubMed  CAS  Google Scholar 

  61. Farooqi IS, Matarese G, Lord GM et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103

    PubMed  CAS  Google Scholar 

  62. Farooqi IS, Jebb SA, Langmack G et al. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879–884

    Article  PubMed  CAS  Google Scholar 

  63. Farooqi IS, O’Rahilly S (2005) Monogenic obesity in humans. Annu Rev Med 56:443–458

    Article  PubMed  CAS  Google Scholar 

  64. Farooqi IS, Wangensteen T, Collins S et al. (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356:237–247

    Article  PubMed  CAS  Google Scholar 

  65. Mergen M, Mergen H, Ozata M, Oner R, Oner C (2001) A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 86:3448–3451

    Article  PubMed  CAS  Google Scholar 

  66. Lubrano-Berthelier C, Dubern B, Lacorte JM et al. (2006) Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab 91:1811–1818

    Article  PubMed  CAS  Google Scholar 

  67. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF (2003) Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 348:1096–1103

    Article  PubMed  CAS  Google Scholar 

  68. Farooqi IS (2005) Genetic and hereditary aspects of childhood obesity. Best Pract Res Clin Endocrinol Metab 19:359–374

    Article  PubMed  CAS  Google Scholar 

  69. Santini F, Maffei M, Pelosini C, Salvetti G, Scartabelli G, Pinchera A (2009) Melanocortin-4 receptor mutations in obesity. Adv Clin Chem 48:95–109

    Article  PubMed  CAS  Google Scholar 

  70. Stutzmann F, Tan K, Vatin V et al. (2008) Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57:2511–2518

    Article  PubMed  CAS  Google Scholar 

  71. Dempfle A, Hinney A, Heinzel-Gutenbrunner M et al. (2004) Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 41:795–800

    Article  PubMed  CAS  Google Scholar 

  72. Rivera G, Bocanegra-Garcia V, Galiano S et al. (2008) Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity. Curr Med Chem 15:1025–1043

    Article  PubMed  CAS  Google Scholar 

  73. August GP, Caprio S, Fennoy I et al. (2008) Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 93:4576–4599

    Article  PubMed  CAS  Google Scholar 

  74. Hannon TS, Rao G, Arslanian SA (2005) Childhood obesity and type 2 diabetes mellitus. Pediatrics 116:473–480

    Article  PubMed  Google Scholar 

  75. Jones KL (2008) Role of obesity in complicating and confusing the diagnosis and treatment of diabetes in children. Pediatrics 121:361–368

    Article  PubMed  Google Scholar 

  76. Weiss R, Dziura J, Burgert TS et al. (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374

    Article  PubMed  CAS  Google Scholar 

  77. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20

    Google Scholar 

  78. Tuomilehto J, Lindstrom J, Eriksson JG et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350

    Article  PubMed  CAS  Google Scholar 

  79. Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403

    Article  PubMed  CAS  Google Scholar 

  80. Barlow SE, Dietz WH (1998) Obesity evaluation and treatment: expert committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102:E29

    Article  PubMed  CAS  Google Scholar 

  81. Mauriac P (1930) Gros ventre, hepatomegalie. Troubles de al croissance chez les enfants diabetiques traits depuis plusieurs annees par l’insuline. Gaz Hebd Sci Med Bordeaux 51:402–404

    Google Scholar 

  82. Kim MS, Quintos JB (2008) Mauriac syndrome: growth failure and type 1 diabetes mellitus. Pediatr Endocrinol Rev 5(Suppl 4):989–993

    PubMed  Google Scholar 

  83. Albright F, Burnett CH, Smith PH, Parson W (1942) Pseudohypoparathyroidism: an example of Seabright-Bantam syndrome. Endocrinology 30:922–932

    CAS  Google Scholar 

  84. Tashjian AH Jr, Frantz AG, Lee JB (1966) Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A 56:1138–1142

    Article  PubMed  CAS  Google Scholar 

  85. Mann JB, Alterman S, Hills AG (1962) Albright’s hereditary osteodystrophy comprising pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. With a report of two cases representing the complete syndrome occurring in successive generations. Ann Intern Med 56:315–342

    PubMed  CAS  Google Scholar 

  86. Eyre WG, Reed WB (1971) Albright’s hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol 104:634–642

    Article  PubMed  CAS  Google Scholar 

  87. Farfel Z, Brothers VM, Brickman AS, Conte F, Neer R, Bourne HR (1981) Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proc Natl Acad Sci USA 78:3098–3102

    Article  PubMed  CAS  Google Scholar 

  88. Levine MA (2000) Clinical spectrum and pathogenesis of pseudohypoparathyroidism. Rev Endocr Metab Disord 1:265–274

    Article  PubMed  CAS  Google Scholar 

  89. Mantovani G, Spada A (2006) Mutations in the Gs alpha gene causing hormone resistance. Best Pract Res Clin Endocrinol Metab 20:501–513

    Article  PubMed  CAS  Google Scholar 

  90. Albright F, Forbes AP, Henneman PH (1952) Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians 65:337–350

    PubMed  CAS  Google Scholar 

  91. Wemeau JL, Balavoine AS, Ladsous M, Velayoudom-Cephise FL, Vlaeminck-Guillem V (2006) Multihormonal resistance to parathyroid hormone, thyroid stimulating hormone, and other hormonal and neurosensory stimuli in patients with pseudohypoparathyroidism. J Pediatr Endocrinol Metab 19(Suppl 2):653–661

    Article  PubMed  CAS  Google Scholar 

  92. Germain-Lee EL (2006) Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a. Pediatr Endocrinol Rev 3(Suppl 2):318–327

    PubMed  Google Scholar 

  93. Weinstein LS, Yu S, Warner DR, Liu J (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675–705

    Article  PubMed  CAS  Google Scholar 

  94. Levine MA, Downs RW Jr, Moses AM et al. (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556

    Article  PubMed  CAS  Google Scholar 

  95. Mantovani G, de Sanctis L, Barbieri AM et al. (2010) Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 95:651–658

    Article  PubMed  CAS  Google Scholar 

  96. Bastepe M (2008) The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol 626:27–40

    Article  PubMed  CAS  Google Scholar 

  97. Hayward BE, Barlier A, Korbonits M et al. (2001) Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107:R31–R36

    Article  PubMed  CAS  Google Scholar 

  98. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A (2002) The Gs-alpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87:4736–4740

    Article  PubMed  CAS  Google Scholar 

  99. Nwosu BU, Lee MM (2009) Pseudohypoparathyroidism type 1a and insulin resistance in a child. Nat Rev Endocrinol 5:345–350

    Article  PubMed  Google Scholar 

  100. Farfel Z, Friedman E (1986) Mental deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency. Ann Intern Med 105:197–199

    PubMed  CAS  Google Scholar 

  101. Drezner MK, Neelon FA, Haussler M, McPherson HT, Lebovitz HE (1976) 1, 25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab 42:621–628

    Article  PubMed  CAS  Google Scholar 

  102. Metz SA, Baylink DJ, Hughes MR, Haussler MR, Robertson RP (1977) Selective deficiency of 1, 25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. N Engl J Med 297:1084–1090

    Article  PubMed  CAS  Google Scholar 

  103. Al-Salameh A, Despert F, Kottler ML, Linglart A, Carel JC, Lecomte P (2010) Resistance to epinephrine and hypersensitivity (hyperresponsiveness) to CB1 antagonists in a patient with pseudohypoparathyroidism type Ic. Eur J Endocrinol 162:819–824

    Article  PubMed  CAS  Google Scholar 

  104. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z (2001) Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 11:137–165

    Article  PubMed  CAS  Google Scholar 

  105. Carrel AL, Allen DB (2000) Effects of growth hormone on body composition and bone metabolism. Endocrine 12:163–172

    Article  PubMed  CAS  Google Scholar 

  106. Laron Z, Pertzelan A, Karp M (1968) Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 4:883–894

    PubMed  CAS  Google Scholar 

  107. Najjar SS, Khachadurian AK, Ilbawi MN, Blizzard RM (1971) Dwarfism with elevated levels of plasma growth hormone. N Engl J Med 284:809–812

    Article  PubMed  CAS  Google Scholar 

  108. Savage MO, Storr HL, Chan LF, Grossman AB (2007) Diagnosis and treatment of pediatric Cushing’s disease. Pituitary 10:365–371

    Article  PubMed  Google Scholar 

  109. Storr HL, Chan LF, Grossman AB, Savage MO (2007) Paediatric Cushing’s syndrome: epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 18:167–174

    Article  PubMed  CAS  Google Scholar 

  110. Fahlbusch R, Honegger J, Buchfelder M (1994) Neurosurgical management of Cushing’s disease in children. In: Savage MO, Bourguignon J-P, Grossman AB (eds) Frontiers in paediatric neuroendocrinology. Blackwell Scientific Publications, Oxford, pp 68–72

    Google Scholar 

  111. Storr HL, Afshar F, Matson M et al. (2005) Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing’s disease. Eur J Endocrinol 152:825–833

    Article  PubMed  CAS  Google Scholar 

  112. Chan LF, Storr HL, Grossman AB, Savage MO (2007) Pediatric Cushing’s syndrome: clinical features, diagnosis, and treatment. Arq Bras Endocrinol Metab 51:1261–1271

    Article  Google Scholar 

  113. Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagne N, Blanchard H (1997) Childhood adrenocortical tumors: case series and reevaluation of prognosis – a 24-year experience. J Pediatr Surg 32:911–915

    Article  PubMed  CAS  Google Scholar 

  114. Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623

    Article  PubMed  CAS  Google Scholar 

  115. Beauregard C, Dickstein G, LaCroix A (2002) Classic and recent etiologies of Cushing’s syndrome: diagnosis and therapy. Treat Endocrinol 1:79–94

    Article  PubMed  Google Scholar 

  116. Leong GM, Abad V, Charmandari E et al. (2007) Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood. J Bone Miner Res 22:110–118

    Article  PubMed  Google Scholar 

  117. Lorini R, Gastaldi R, Traggiai C, Perucchin PP (2003) Hashimoto’s thyroiditis. Pediatr Endocrinol Rev 1(Suppl 2):205–211

    PubMed  Google Scholar 

  118. de Vries L, Bulvik S, Phillip M (2009) Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child 94:33–37

    Article  PubMed  Google Scholar 

  119. Reutrakul S, Hathout EH, Janner D et al. (2004) Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance. Thyroid 14:311–319

    Article  PubMed  CAS  Google Scholar 

  120. Duntas LH (2008) Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4:454–460

    Article  PubMed  CAS  Google Scholar 

  121. Pinkney J, Wilding J, Williams G, MacFarlane I (2002) Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 3:27–34

    Article  PubMed  CAS  Google Scholar 

  122. Bray GA, Gallagher TF Jr (1975) Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine (Baltimore) 54:301–330

    Article  CAS  Google Scholar 

  123. Bray GA (1984) Syndromes of hypothalamic obesity in man. Pediatr Ann 13:525–536

    PubMed  CAS  Google Scholar 

  124. Nussey SS, Whitehead SA (2010) Chapter 7: the pituitary gland. In: Endocrinology: an integrated approach. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=endocrin&part=A1257&renertype=box&id=A1272. Accessed 23 March 2010

  125. Hetherington AW, Ranson S (1940) Hypothalamic lesions and adiposity in the rat. Anat Rec 78:149–172

    Article  Google Scholar 

  126. Anand BK, Brobeck JR (1951) Localization of a “feeding center” in the hypothalamus of the rat. Proc Soc Exp Biol Med 77:323–324

    PubMed  CAS  Google Scholar 

  127. Elmquist JK, Elias CF, Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221–232

    Article  PubMed  CAS  Google Scholar 

  128. Berthoud HR, Jeanrenaud B (1979) Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 105:146–151

    Article  PubMed  CAS  Google Scholar 

  129. Rohner-Jeanrenaud F, Jeanrenaud B (1980) Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat. J Clin Invest 65:902–910

    Article  PubMed  CAS  Google Scholar 

  130. Werner SC (1941) A study of untreated Frohlich’s Syndrome without brain tumor: adiposogenital dystrophy. J Clin Endocrinol Metab 1:134–137

    Article  Google Scholar 

  131. U.S. Cancer Statistics Working Group (2010) United States cancer statistics: 2004 incidence and mortality. Available at: http://www.cdc.gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2004_Incidence_and_Mortality.pdf. Accessed 23 March 2010

  132. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551

    Article  PubMed  CAS  Google Scholar 

  133. Lafferty AR, Chrousos GP (1999) Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84:4317–4323

    Article  PubMed  CAS  Google Scholar 

  134. Sklar CA (1994) Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18–20

    Article  PubMed  Google Scholar 

  135. May JA, Krieger MD, Bowen I, Geffner ME (2006) Craniopharyngioma in childhood. Adv Pediatr 53:183–209

    Article  PubMed  Google Scholar 

  136. Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid ­postoperative weight gain. Acta Paediatr Scand 77:587–592

    Article  PubMed  CAS  Google Scholar 

  137. Muller HL, Emser A, Faldum A et al. (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89:3298–3305

    Article  PubMed  CAS  Google Scholar 

  138. de Vries L, Lazar L, Phillip M (2003) Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16:703–710

    Article  PubMed  Google Scholar 

  139. Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69:193–202

    Article  PubMed  CAS  Google Scholar 

  140. Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P (1990) Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73:3–11

    Article  PubMed  CAS  Google Scholar 

  141. Hader WJ, Steinbok P, Hukin J, Fryer C (2000) Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33:211–218

    Article  PubMed  CAS  Google Scholar 

  142. Mottolese C, Stan H, Hermier M et al. (2001) Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv Syst 17:724–730

    Article  PubMed  CAS  Google Scholar 

  143. Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40:263–269

    Article  PubMed  CAS  Google Scholar 

  144. Savas A, Erdem A, Tun K, Kanpolat Y (2000) Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46:213–216

    Article  PubMed  CAS  Google Scholar 

  145. Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87:3993–3996

    Article  PubMed  CAS  Google Scholar 

  146. Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125

    PubMed  CAS  Google Scholar 

  147. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A (1991) Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13–21

    PubMed  CAS  Google Scholar 

  148. Geffner M, Lundberg M, Koltowska-Haggstrom M et al. (2004) Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89:5435–5440

    Article  PubMed  CAS  Google Scholar 

  149. Lustig RH, Hinds PS, Ringwald-Smith K et al. (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586–2592

    Article  PubMed  CAS  Google Scholar 

  150. Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156:887–892

    PubMed  Google Scholar 

  151. Collins J, Mattar S, Qureshi F et al. (2007) Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis 3:147–152

    Article  PubMed  Google Scholar 

  152. Nadler EP, Youn HA, Ginsburg HB, Ren CJ, Fielding GA (2007) Short-term results in 53 US obese pediatric patients treated with laparoscopic adjustable gastric banding. J Pediatr Surg 42:137–141

    Article  PubMed  Google Scholar 

  153. Inge TH, Pfluger P, Zeller M et al. (2007) Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 3:606–609

    Article  PubMed  Google Scholar 

  154. Rottembourg D, O’Gorman CS, Urbach S et al. (2009) Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 22:867–872

    Article  PubMed  Google Scholar 

  155. Schultes B, Ernst B, Schmid F, Thurnheer M (2009) Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol 161:201–206

    Article  PubMed  CAS  Google Scholar 

  156. Davies DJ, Baxter JM, Baxter JN (2007) Nutritional deficiencies after bariatric surgery. Obes Surg 17:1150–1158

    Article  PubMed  CAS  Google Scholar 

  157. Breum L, Fernstrom MH (2001) Drug-induced obesity. In: Bjorntorp P (ed) International textbook of obesity. Wiley, Chichester, pp 269–281

    Chapter  Google Scholar 

  158. Hopkins RL, Leinung MC (2005) Exogenous Cushing’s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 34:371–384, ix

    Google Scholar 

  159. American Diabetes Association (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596–601

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novo Nordisk Inc., Princeton, NJ, USA

    Paula M. Hale MD

Authors
  1. Paula M. Hale MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tulay T. Cushman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward S. Kimball
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aji Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rebecca Gusic Shaffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. UT Health Science Center at Memphis, Division of Pediatric Endocrinology and, Le Bonheur Children's Hospital, North Dunlap Street 50, Memphis, 38103, Tennessee, USA

    Robert J. Ferry, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hale, P.M., Cushman, T.T., Kimball, E.S., Nair, A., Shaffer, R.G. (2011). Secondary Causes of Obesity in Childhood. In: Ferry, Jr., R. (eds) Management of Pediatric Obesity and Diabetes. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-60327-256-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-256-8_16

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-255-1

  • Online ISBN: 978-1-60327-256-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation